JAMA oncology, 2019-04, Vol.5 (4), p.570
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program
- Ist Teil von
- JAMA oncology, 2019-04, Vol.5 (4), p.570
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 2374-2437eISSN: 2374-2445DOI: 10.1001/jamaoncol.2018.7002Titel-ID: cdi_pubmed_primary_30816938
- Format
- –
- Schlagworte
- Adolescent, Adult, Antineoplastic Agents - adverse effects, Antineoplastic Agents - therapeutic use, Compassionate Use Trials - statistics & numerical data, Drugs, Investigational - adverse effects, Drugs, Investigational - therapeutic use, Female, Humans, Male, Middle Aged, Neoplasms - drug therapy, Program Evaluation, Treatment Outcome, United States, United States Food and Drug Administration, Young Adult